CLS · Company research

Celestica, Inc. (CLS): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 2026371.57$41,428,786,00040893086000.0038.86351577698942—0.52393776825274648.817261737538841416.7078504597515728281.63688647178789938855

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.